dismiss

Come visit us at Booth 901 at AHRMM in Washington, DC
Mark your calendars! On August 2nd is our upcoming LIVE Clean Sweep Auction

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Oncology Homepage

RayStation reports eight more purchases of proton treatment planning system Total of 35 sold worldwide

Henry Ford Cancer Institute treats first patient with ViewRay's MRIdian Linac 'Takes off the blindfold' for radiation oncologists

Beaumont Health opens Michigan's first proton therapy center U.S. PT market to exceed $1 billion by 2022

ASTRO releases updated insurance coverage recommendations for proton therapy New research supports the modifications

Konica Minolta to acquire Ambry Genetics in $1 billion deal Will be 'first in a series' of precision medicine acquisitions

Canadian researchers find a more cost-effective approach to CT lung cancer screening Involves smoking cessation initiatives

Varian gets FDA nod for Halcyon radiotherapy system Allows for simplified, efficient cancer treatment

Isala and Elekta sign 15-year radiotherapy equipment partnership Will upgrade to state-of-the-art technology

Supplemental breast MR superior to ultrasound for screening breast cancer survivors But what about cost-effectiveness?

German researchers find sweet alternative to conventional MR contrast agents Imaging with glucose using 7T MR scanner

Breast density and mammographic sensitivity have a strong linear correlation

by Christina Hwang , Contributing Reporter
A linear relationship between breast density and mammographic sensitivity was further evaluated by research published in the American Journal of Roentgenology.

A team from Elizabeth Wende Breast Care (EWBC) conducted a study over a four year time period, collecting the information of 771 patients with breast cancer. Breast density was measured using the American College of Radiology’s BI-RADS density categories. VolparaDensity, a software tool that generates a breast density percentage and a Volpara Density Grade — similar to the BI-RADS categories — was also used to assess breast density.

Story Continues Below Advertisement

qualiTEE - reliabiliTEE - repairabiliTEE - we guaranTEE

Bayer HealthCare Multi Vendor Service will repair your transducer with the same precision and care you provide to your patients. Now offering TotalREPAIR on 140 transducer models! Call us at 1-844-5100 or visit www.mvs.bayer.com to set up an order today.



When using the BI-RADS categories to classify breast density as almost entirely fatty, scattered density, heterogeneously dense, and extremely dense, the researchers found that mammographic sensitivity was 82 percent, 90 percent, 84 percent and 66 percent, respectively.

According to the researchers, the linear relationship between mammographic sensitivity and breast density was more apparent when using the Volpara Density Grade than when using the BI-RADS categories. Using VolparaDensity categories, the mammographic sensitivity was 95 percent, 89 percent, 83 percent and 65 percent.

“The visual assessment of determining BI-RADS categories tends to be subjective from radiologist to radiologist and less reproducible depending on the experience of the radiologist, volume of interpretation by the radiologist, prior mammogram density assignment – and is much less consistent,” Dr. Stamatia Destounis, Elizabeth Wende Breast Care, clinical professor, University of Rochester School of Medicine & Dentistry, told HCB News.

Results from the study showed that denser breasts were associated with the risk of being diagnosed with an interval cancer, a cancer that is not detected by screening but possibly palpated by the patient or her physician.

“Prior studies have detected higher rates of missed cancers in the denser breast tissue leading to higher numbers of interval cancers, but also higher breast cancer detection rates in denser breasts,” Destounis said.

Within each density category, the researchers also discovered there was a wide range of mammographic sensitivity. For example, women who were categorized in the “low” Volpara Density Grade category four had a sensitivity of 72 percent, and women in the “high” category four had a sensitivity of 58 percent.

According to Destounis, these results suggest that some women with dense breasts may still have an acceptable level of sensitivity and additional screening is unnecessary. Instead of giving women a density score, the patient could be given the average sensitivity for women in the same breast density, so she could make a more educated decision on whether or not she needs additional screening.

“Correct assessment of a woman’s breast density is important, as it can help to appropriately determine who may benefit most from adjunct screening, such as screening ultrasound,” said Destounis. “This is ever the more important as more states adopt density notification legislation, and demand increases for additional screening services.”

Oncology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED